(MBLY) Mobileye Global Common Stock - Overview
Exchange: NASDAQ •
Country: Israel •
Currency: USD •
Type: Common Stock •
ISIN: US60741F1049
Stock: Camera, Chipset, Cloud, Fleet, Pilot
Total Rating 23
Risk 98
Buy Signal -1.02
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 63.7% |
| Relative Tail Risk | -5.66% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.88 |
| Alpha | -70.39 |
| Character TTM | |
|---|---|
| Beta | 1.752 |
| Beta Downside | 1.473 |
| Drawdowns 3y | |
|---|---|
| Max DD | 82.14% |
| CAGR/Max DD | -0.50 |
Description: MBLY Mobileye Global Common Stock January 03, 2026
Mobileye Global Inc. (NASDAQ: MBLY) designs, manufactures and sells advanced driver-assistance systems (ADAS) and full-stack autonomous-driving solutions for OEMs, automotive suppliers and fleet operators. Its product hierarchy ranges from Base ADAS (front-camera safety features) through Cloud-Enhanced and Surround ADAS (hands-off highway functions) to end-to-end platforms such as SuperVision, Mobileye Chauffeur and Mobileye Drive, all powered by the proprietary EyeQ system-on-chip and the True Redundancy AI architecture.
In FY 2023 the company reported roughly $1.5 billion of revenue-a 30 % year-over-year increase-driven by expanding shipments of EyeQ chips (≈10 million units) and new contracts with Tier-1 suppliers for robotaxi deployments. The ADAS market is projected to reach $90 billion by 2027, fueled by tightening safety regulations (e.g., EU mandatory lane-keeping assist) and the broader electrification-autonomy convergence that raises vehicle software spend as a larger share of total cost of ownership.
For a deeper dive into Mobileye’s valuation multiples, growth assumptions and competitive positioning, you may find ValueRay’s analyst toolkit useful.
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income: -392.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA 1.72 > 1.0 |
| NWC/Revenue: 109.4% < 20% (prev 111.3%; Δ -1.91% < -1%) |
| CFO/TA 0.05 > 3% & CFO 613.2m > Net Income -392.0m |
| Net Debt (-1.84b) to EBITDA (122.0m): -15.05 < 3 |
| Current Ratio: 6.10 > 1.5 & < 3 |
| Outstanding Shares: last quarter (814.0m) vs 12m ago 0.62% < -2% |
| Gross Margin: 47.73% > 18% (prev 0.45%; Δ 4728 % > 0.5%) |
| Asset Turnover: 15.11% > 50% (prev 13.15%; Δ 1.96% > 0%) |
| Interest Coverage Ratio: -21.94 > 6 (EBITDA TTM 122.0m / Interest Expense TTM -18.0m) |
Altman Z'' 10.00
| A: 0.17 (Total Current Assets 2.48b - Total Current Liabilities 406.0m) / Total Assets 12.49b |
| B: -0.27 (Retained Earnings -3.33b / Total Assets 12.49b) |
| C: -0.03 (EBIT TTM -395.0m / Avg Total Assets 12.54b) |
| D: 19.45 (Book Value of Equity 11.88b / Total Liabilities 611.0m) |
| Altman-Z'' Score: 20.43 = AAA |
Beneish M -3.46
| DSRI: 0.54 (Receivables 131.0m/212.0m, Revenue 1.89b/1.65b) |
| GMI: 0.94 (GM 47.73% / 44.80%) |
| AQI: 0.97 (AQ_t 0.76 / AQ_t-1 0.79) |
| SGI: 1.15 (Revenue 1.89b / 1.65b) |
| TATA: -0.08 (NI -392.0m - CFO 613.2m) / TA 12.49b) |
| Beneish M-Score: -3.46 (Cap -4..+1) = AA |
What is the price of MBLY shares?
As of February 07, 2026, the stock is trading at USD 8.71 with a total of 9,405,407 shares traded.
Over the past week, the price has changed by -3.01%, over one month by -28.49%, over three months by -30.76% and over the past year by -47.08%.
Over the past week, the price has changed by -3.01%, over one month by -28.49%, over three months by -30.76% and over the past year by -47.08%.
Is MBLY a buy, sell or hold?
Mobileye Global Common Stock has received a consensus analysts rating of 3.89.
Therefore, it is recommended to buy MBLY.
- StrongBuy: 12
- Buy: 2
- Hold: 13
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the MBLY price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 15.6 | 79.6% |
| Analysts Target Price | 15.6 | 79.6% |
| ValueRay Target Price | 6.5 | -25.3% |
MBLY Fundamental Data Overview February 02, 2026
P/E Forward = 28.9855
P/S = 3.8583
P/B = 0.6349
P/EG = 0.4828
Revenue TTM = 1.89b USD
EBIT TTM = -395.0m USD
EBITDA TTM = 122.0m USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = 67.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -1.84b USD (from netDebt column, last quarter)
Enterprise Value = 5.54b USD (7.31b + Debt 67.0m - CCE 1.84b)
Interest Coverage Ratio = -21.94 (Ebit TTM -395.0m / Interest Expense TTM -18.0m)
EV/FCF = 10.41x (Enterprise Value 5.54b / FCF TTM 532.2m)
FCF Yield = 9.61% (FCF TTM 532.2m / Enterprise Value 5.54b)
FCF Margin = 28.10% (FCF TTM 532.2m / Revenue TTM 1.89b)
Net Margin = -20.70% (Net Income TTM -392.0m / Revenue TTM 1.89b)
Gross Margin = 47.73% ((Revenue TTM 1.89b - Cost of Revenue TTM 990.0m) / Revenue TTM)
Gross Margin QoQ = 45.29% (prev 48.21%)
Tobins Q-Ratio = 0.44 (Enterprise Value 5.54b / Total Assets 12.49b)
Interest Expense / Debt = 11.94% (Interest Expense 8.00m / Debt 67.0m)
Taxrate = 21.0% (US default 21%)
NOPAT = -312.1m (EBIT -395.0m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 6.10 (Total Current Assets 2.48b / Total Current Liabilities 406.0m)
Debt / Equity = 0.01 (Debt 67.0m / totalStockholderEquity, last quarter 11.88b)
Debt / EBITDA = -15.05 (Net Debt -1.84b / EBITDA 122.0m)
Debt / FCF = -3.45 (Net Debt -1.84b / FCF TTM 532.2m)
Total Stockholder Equity = 11.98b (last 4 quarters mean from totalStockholderEquity)
RoA = -3.13% (Net Income -392.0m / Total Assets 12.49b)
RoE = -3.27% (Net Income TTM -392.0m / Total Stockholder Equity 11.98b)
RoCE = -3.27% (EBIT -395.0m / Capital Employed (Total Assets 12.49b - Current Liab 406.0m))
RoIC = -2.60% (negative operating profit) (NOPAT -312.1m / Invested Capital 12.02b)
WACC = 12.34% (E(7.31b)/V(7.37b) * Re(12.37%) + D(67.0m)/V(7.37b) * Rd(11.94%) * (1-Tc(0.21)))
Discount Rate = 12.37% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.49%
[DCF Debug] Terminal Value 64.47% ; FCFF base≈446.9m ; Y1≈459.8m ; Y5≈515.5m
Fair Price DCF = 31.04 (EV 4.87b - Net Debt -1.84b = Equity 6.70b / Shares 216.0m; r=12.34% [WACC]; 5y FCF grow 2.89% → 2.90% )
EPS Correlation: -48.25 | EPS CAGR: -24.57% | SUE: -4.0 | # QB: 0
Revenue Correlation: 4.31 | Revenue CAGR: 3.36% | SUE: 0.53 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.09 | Chg30d=+0.014 | Revisions Net=+5 | Analysts=21
EPS current Year (2026-12-31): EPS=0.26 | Chg30d=-0.151 | Revisions Net=-20 | Growth EPS=-26.9% | Growth Revenue=+3.0%
EPS next Year (2027-12-31): EPS=0.38 | Chg30d=-0.226 | Revisions Net=-18 | Growth EPS=+49.2% | Growth Revenue=+16.4%
P/S = 3.8583
P/B = 0.6349
P/EG = 0.4828
Revenue TTM = 1.89b USD
EBIT TTM = -395.0m USD
EBITDA TTM = 122.0m USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = 67.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -1.84b USD (from netDebt column, last quarter)
Enterprise Value = 5.54b USD (7.31b + Debt 67.0m - CCE 1.84b)
Interest Coverage Ratio = -21.94 (Ebit TTM -395.0m / Interest Expense TTM -18.0m)
EV/FCF = 10.41x (Enterprise Value 5.54b / FCF TTM 532.2m)
FCF Yield = 9.61% (FCF TTM 532.2m / Enterprise Value 5.54b)
FCF Margin = 28.10% (FCF TTM 532.2m / Revenue TTM 1.89b)
Net Margin = -20.70% (Net Income TTM -392.0m / Revenue TTM 1.89b)
Gross Margin = 47.73% ((Revenue TTM 1.89b - Cost of Revenue TTM 990.0m) / Revenue TTM)
Gross Margin QoQ = 45.29% (prev 48.21%)
Tobins Q-Ratio = 0.44 (Enterprise Value 5.54b / Total Assets 12.49b)
Interest Expense / Debt = 11.94% (Interest Expense 8.00m / Debt 67.0m)
Taxrate = 21.0% (US default 21%)
NOPAT = -312.1m (EBIT -395.0m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 6.10 (Total Current Assets 2.48b / Total Current Liabilities 406.0m)
Debt / Equity = 0.01 (Debt 67.0m / totalStockholderEquity, last quarter 11.88b)
Debt / EBITDA = -15.05 (Net Debt -1.84b / EBITDA 122.0m)
Debt / FCF = -3.45 (Net Debt -1.84b / FCF TTM 532.2m)
Total Stockholder Equity = 11.98b (last 4 quarters mean from totalStockholderEquity)
RoA = -3.13% (Net Income -392.0m / Total Assets 12.49b)
RoE = -3.27% (Net Income TTM -392.0m / Total Stockholder Equity 11.98b)
RoCE = -3.27% (EBIT -395.0m / Capital Employed (Total Assets 12.49b - Current Liab 406.0m))
RoIC = -2.60% (negative operating profit) (NOPAT -312.1m / Invested Capital 12.02b)
WACC = 12.34% (E(7.31b)/V(7.37b) * Re(12.37%) + D(67.0m)/V(7.37b) * Rd(11.94%) * (1-Tc(0.21)))
Discount Rate = 12.37% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.49%
[DCF Debug] Terminal Value 64.47% ; FCFF base≈446.9m ; Y1≈459.8m ; Y5≈515.5m
Fair Price DCF = 31.04 (EV 4.87b - Net Debt -1.84b = Equity 6.70b / Shares 216.0m; r=12.34% [WACC]; 5y FCF grow 2.89% → 2.90% )
EPS Correlation: -48.25 | EPS CAGR: -24.57% | SUE: -4.0 | # QB: 0
Revenue Correlation: 4.31 | Revenue CAGR: 3.36% | SUE: 0.53 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.09 | Chg30d=+0.014 | Revisions Net=+5 | Analysts=21
EPS current Year (2026-12-31): EPS=0.26 | Chg30d=-0.151 | Revisions Net=-20 | Growth EPS=-26.9% | Growth Revenue=+3.0%
EPS next Year (2027-12-31): EPS=0.38 | Chg30d=-0.226 | Revisions Net=-18 | Growth EPS=+49.2% | Growth Revenue=+16.4%